Back to search

University of Ioannina

Διερεύνηση επαγωγής του ανοσολογικού κυτταρικού θανάτου (ICD) από στοχευτικά και κυτταροτοξικά αντινεοπλασματικά φάρμακα σε συμπαγείς όγκους και in vivo μελέτη βιοδεικτών ICD σε ασθενείς

Abstract

dc:description

Colorectal cancer is one of the most frequently encountered malignancies. Both cytotoxic and targeted antineoplastic treatments, have prolonged survival and ameliorated quality of life of affected patients. Agents very often employed against colorectal cancer, such as oxaliplatin and cetuximab, may also enhance host’s immunogenicity, by inducing Immunogenic Cell Death (ICD). ICD induction in patients has not yet been systematically studied. We aimed to investigate changes in local immune response, during antineoplastic treatment, and research for relative biomarkers, in colorectal cancer patients. A retrospective study of 20 colorectal cancer patient cases, with available tissue material from 1 to 2 tumor sites was performed. Tissue material was evaluated for density of Tumor Infiltrating Lymphocytes (TILs), as well as CD3, CD8, CD4 and FOXP3 positive subpopulations, both in primary and metastatic tumor sites. A significant association was shown between increased stromal and total CD3 positive TILs density and male sex, as well as between better differentiated neoplasms and stromal/total CD8 positive TILs concentration, regarding the primary tumor site. 95% of patients received oxaliplatin as perioperative and/or systematic treatment, while 15% and 45% of patients received neoadjuvant/adjuvant and systematic treatment with cetuximab, respectively. For patients with available tissue material from both primary and secondary tumor sites, we observed an increased concentration of stromal and total CD8, CD3, CD4 and FOXP3 positive TILs, in the secondary cancer sites, compared to the primary site. Median overall survival was 63 months. No association between TILs subpopulations in the primary or secondary tumor site and patient overall or progression free survival was found. Immune system activation may increase during disease course, and in parallel with the antineoplastic treatment administration, although increased in local immune infiltration did not seem to affect patient survival. Immune enhancing effect of broadly used cytotoxic and targeted agents, may serve a background for immunotherapy administration, as salvage or maintenance treatment, especially in patients whose tumors do not express established immunotherapy biomarkers.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gazouli, Ioanna
  • Γαζούλη, Ιωάννα

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59006

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gazouli, Ioanna; Γαζούλη, Ιωάννα. Διερεύνηση επαγωγής του ανοσολογικού κυτταρικού θανάτου (ICD) από στοχευτικά και κυτταροτοξικά αντινεοπλασματικά φάρμακα σε συμπαγείς όγκους και in vivo μελέτη βιοδεικτών ICD σε ασθενείς. University of Ioannina, 2024. http://hdl.handle.net/10442/hedi/59006